About 31,600 results
Open links in new tab
  1. IDSA 2025 Guideline Update on Complicated Urinary Tract Infections

    Jul 17, 2025 · Some patients with cUTI can be managed entirely with oral antibiotics in the outpatient setting. Please see a discussion of this topic in Clinical Question 1, under the section on “ Oral …

  2. 2025 IDSA Complicated Urinary Tract Infection (cUTI) – New Guidelines

    Jul 24, 2025 · As more data emerged, the IDSA recognized the need for cUTI guidelines for women and men. These new guidelines cover UTI classifications, antibiotic selection recommendations, antibiotic …

  3. SCI Model Systems Complicated Urinary Tract Infection (cUTI

    This is the first international and empirical initiative to establish cUTI symptoms-based guidelines for cUTI in SCI/D. These guidelines provide a coherent and evidence-based approach to decision …

  4. Complicated Urinary Tract Infections: Developing Drugs for ... - FDA

    May 7, 2020 · Clinical / Antimicrobial The purpose of this guidance is to assist sponsors in the clinical development of drugs for the treatment of complicated urinary tract infections (cUTIs).2 Specifically ...

  5. The Pediatric Infectious Disease Journal

    Accurate diagnosis and management of cUTI limit morbidity and mortality from sepsis and long-term renal damage. However, most trials of UTI in children have excluded those with cUTI, and …

  6. Epidemiology, definition and treatment of complicated urinary …

    Aug 25, 2020 · The risk of developing a cUTI is increased in various patient populations, typically as a result of reduced clearance of uropathogens or increased bacterial colonization of the urinary tract.

  7. cUTI: MerLion Pharmaceuticals

    A low pH, acidic environment is often the physiological consequence of a bacterial infection and also very frequent in the urine of patients suffering from cUTI. Under these conditions, a number of …

  8. Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for ...

    Mar 6, 2019 · ZTI-01 was effective for treatment of cUTI including AP and offers a new IV therapeutic option with a differentiated MOA for patients with serious Gram-negative infections.

  9. Recommendation: In patients suspected of cUTI, empiric antibiotic therapy selection should account for patient-specific considerations (e.g. risk of allergic reaction, contraindications, or drug-drug …

  10. The patient population should include patients with cUTI, and at least 30 percent of the patient population should have pyelonephritis for the indication for treatment of cUTI and...